Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management
Medicinal Research Reviews · 2026-01 · 46 (1) · 272-298
DOI: 10.1002/med.70013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 29.09.2025. Verfasst von Baljinder Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmaceutical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia. Hauptthemen laut MEDLINE: Alzheimer Disease, Autophagy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders. This review aims to provide a comprehensive overview of autophagy's role in neurodegenerative diseases, focusing on AD. The pathogenesis of AD involves the accumulation of misfolded proteins, such as beta‐amyloid (Aβ) and tau, leading to neuronal dysfunction and cognitive impairment. Autophagy can be crucial in clearing these protein aggregates and maintaining cellular homeostasis. Nevertheless, autophagic dysregulation and mitochondrial dysfunction contribute to further progression of neurodegeneration. Furthermore, recent studies have demonstrated the therapeutic potential of several plant‐based phytoconstituents and repurposed molecules that modulate autophagy. These compounds target both mTOR‐dependent and independent pathways, highlighting their potential to alleviate disease pathology. This review aims to pave the way for future research and development in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmaceutical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
- Chemical Biology Unit, Institute of Nano Science and Technology, Mohali, India.
ORCID-Profile: Sanjay Garg
Zitieren
APA
Singh, B., Mahajan, S., Abdella, S., Khan, R., & Garg, S. (2026). Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management. Medicinal Research Reviews, 46(1), 272-298. https://doi.org/10.1002/med.70013
Vancouver
Singh B, Mahajan S, Abdella S, Khan R, Garg S. Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management. Medicinal Research Reviews. 2026;46(1):272-298. doi:10.1002/med.70013
BibTeX
@article{Singh2026,
author = {Singh, Baljinder and Mahajan, Shubham and Abdella, Sadikalmahdi and Khan, Rehan and Garg, Sanjay},
title = {Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {1},
pages = {272--298},
doi = {10.1002/med.70013}
}
EUVIMED